Founded in 2014, Welcome Cure operates in Health Tech industry. Initially focused on delivering homeopathic consultations and treatment plans online, the company has grown to incorporate comprehensive...
Funding stage:
Seed
Last funding:
18/10/2023
Total funding:
$6.48 Mn+
Revenue:
Investors
Employee count:
41
Last 90d
41
Last 90d
Web traffic:
32.76K
32.76K
Last 30d
Last 30d
Glassdoor Rating:
Welcome Cure: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders10
Latest Filing Date30 March 2025- Funding Events12
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Welcome Cure
As of 31 March 2025, Welcome Cure's equity is held by 9 shareholders, with the top three being WelcomeCure, Jawahar Jitendra Shah, and Lal Chandra Singh.
WelcomeCure holds the largest stake in Welcome Cure at 40.5% as of 31 March 2025.
As of 31 March 2025, founders collectively hold 30.5% equity in Welcome Cure.
As of 31 March 2025, investors collectively hold 8.3% equity in Welcome Cure.
Welcome Cure's ESOP pool stands at 9.2% of total equity as of 31 March 2025.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links